If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,790.00    6.00 (0.34%)
Bid:
1,774.00
Ask:
1,780.00
Spread: 6.00 (0.338%)
Market Cap: £527.18m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

UK MoD General Service Respirator order

9 May 2024 07:00

RNS Number : 6927N
Avon Protection PLC
09 May 2024
 

 

9th May 2024

 

Avon Protection plc

("Avon")

 

Avon awarded UK Ministry of Defence General Service Respirator contract worth up to £38m

 

CBRN respirators for all branches of the UK's armed forces to be supplied from Avon's Melksham facility, boosting UK's sovereign CBRN protection capability.

 

We are pleased to announce that Avon Protection has won the tender for the continued supply of the General Service Respirator ("GSR") and associated in service support for the UK Ministry of Defence ("MoD").

 

Avon has been supplying the MoD with GSR masks since 2018 and this new contract award will enable Avon to continue to help protect the lives of people serving in the UK Armed Forces, sustaining the UK's domestic CBRN protection production capability.

 

The contract, over four years, with five further 12-month option periods is valued at up to £38 million.

 

Jos Sclater, Chief Executive Officer at Avon Protection plc, commented:

 

"We are very proud to have won this competitive tender with the UK MoD and to continue supporting the UK's objectives of providing the highest quality, most reliable and trusted protection equipment for the UK's service men and women.

 

As we have seen with the reported deployment of chemical agents in Ukraine and in other recent conflicts, the highest grade CBRN protection is critical to operational capability for warfighters in the evolving reality of near-peer, hybrid warfare.

 

This award is strategically important for Avon. It demonstrates our continued technological leadership in CBRN respiratory protection and provides a strong foundation for our UK business over the medium and long term. We look forward to continuing to provide the UK with a world-leading sovereign capability in CBRN protection from our facility in Melksham and developing new technologies which will provide unparalleled protection for those who defend our nation." 

 

Richard Bloomfield, Head of Electronic Warfare and CBRN at MoD Defence Equipment and Support, commented:

 

"We welcome the award of this contract, which will ensure continued support of the respiratory protection available to our armed forces.

 

We have worked with Avon on supporting GSR for the past 6 years and look forward to continuing this relationship, offering high levels of protection to our troops across the world."

 

 

 

 

 

For further enquiries, please contact:

 

Avon Protection plc

Jos Sclater, Chief Executive Officer

+44 1225 896 848

Rich Cashin, Chief Financial Officer

Gabby Colley, Corporate Affairs Director

Powerscourt

James White

+44 7855 432 699

Maxim Hibbs

avonprotection@powerscourt-group.com

 

About Avon Protection plc:

We are a world leader in protective equipment, with a reputation for innovative design, high-performance quality and specialist materials expertise.

Our two businesses, Avon Protection and Team Wendy, supply our respiratory and head protection portfolio to customers across the globe from our manufacturing sites in the UK and North America.

With over 900 talented people our shared purpose and core beliefs are to be #FIERCE about Protecting Lives. It's why we come to work - and it's what motivates us, every day, to do the best work we can.

For further information, please visit our website www.avon-protection-plc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTUPUUGAUPCGMR
Date   Source Headline
6th Jul 20267:00 amRNSEuropean NATO Respirator Order
26th Jun 20267:06 amRNSNG IHPS Delivery Orders
25th Jun 20263:53 pmRNSHolding(s) in Company
23rd Jun 20267:00 amRNSHolding(s) in Company
22nd Jun 20263:44 pmRNSHolding(s) in Company
8th Jun 20261:37 pmRNSDirector/PDMR Shareholding
13th May 20267:00 amRNSInterim Results
8th May 20267:00 amRNSHolding(s) in Company
6th May 20262:03 pmRNSDirector/PDMR Shareholding
28th Apr 20267:00 amRNSHolding(s) in Company
14th Apr 20267:00 amRNSNotice of Results and Investor Presentation
8th Apr 202612:15 pmRNSHolding(s) in Company
8th Apr 202611:47 amRNSDirector/PDMR Shareholding
27th Mar 20261:23 pmRNSDirector/PDMR Shareholding
6th Mar 20261:23 pmRNSDirectors'/PDMR Shareholdings
6th Mar 20267:00 amRNSNew Filter Order
3rd Mar 20262:34 pmRNSHolding(s) in Company
13th Feb 202611:01 amRNSDirector/PDMR Shareholding
6th Feb 20262:52 pmRNSDirectors'/PDMR Shareholdings
6th Feb 20262:41 pmRNSFinal Dividend Currency Exchange Rate
4th Feb 20264:18 pmRNSHolding(s) in Company
2nd Feb 202610:10 amRNSResult of AGM
30th Jan 20267:00 amRNSAGM & Q1 Trading Update
20th Jan 20263:19 pmRNSDirector/PDMR Shareholding
6th Jan 20261:46 pmRNSDirectors'/PDMR Shareholdings
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
23rd Dec 20259:21 amRNSDirector/PDMR Shareholding
16th Dec 20258:45 amRNSHolding(s) in Company
11th Dec 20253:51 pmRNSHolding(s) in Company
11th Dec 20257:00 amRNSEuropean FM50 Order
9th Dec 202511:58 amRNSDirectors'/PDMR Shareholding
8th Dec 20251:32 pmRNSDirectors'/PDMR Shareholdings
5th Dec 20259:00 amRNSNotice of Annual Report & Accounts and AGM 2026
1st Dec 20256:01 pmRNSDirector Declaration
25th Nov 20253:55 pmRNSHolding(s) in Company
21st Nov 20259:50 amRNSNotification of LTIP & DSBP Awards
12th Nov 20257:00 amRNSPreliminary Results
7th Nov 20259:23 amRNSDirectors'/PDMR Shareholdings
16th Oct 20257:00 amRNSNotice of Results & Investor Presentation via IMC
8th Oct 202510:06 amRNSDirectors'/PDMR Shareholding
15th Sep 20252:51 pmRNSHolding(s) in Company
11th Sep 20254:10 pmRNSHolding(s) in Company
8th Sep 20251:14 pmRNSDirectors'/PDMR Shareholding
13th Aug 20254:59 pmRNSInterim Dividend Currency Exchange Rate
11th Aug 20254:47 pmRNSHolding(s) in Company
7th Aug 20253:10 pmRNSDirectors'/PDMR Shareholdings
17th Jul 20257:00 amRNSDirectors'/PDMR Shareholdings
23rd Jun 20257:00 amRNSUK MoD respirator order for Ukraine
10th Jun 20257:00 amRNSHolding(s) in Company
9th Jun 20259:30 amRNSDirectors'/PDMR Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.